News

Early results from our Sledgehammer Fund have revealed that our TV and press adverts were remembered by nearly half of UK adults, significantly increasing awareness of our cause and the disease.

The Memorial Sloan-Kettering Cancer Center has released new research published in the British Medical Journal today (17 April 2013) which explores whether measuring PSA levels in men aged 40-55 could predict their risk of dying from prostate cancer later in life.

The Prostate Cancer Charity comments on the early data released from the PIVOT trial, which is comparing the 10 year survival benefit of prostate surgery versus observation for 731 men with low to medium risk disease.

The Prostate Cancer Charity comments on research released today (17 April) in the Lancet Oncology, which suggests that a new treatment - focal high-intensity focused ultrasound (focal HIFU) -has the potential to effectively treat prostate tumours with dramatically reduced side-effects compared to traditional methods.

The Prostate Cancer Charity comments on new research, presented as an abstract at the American Association for Cancer Research conference, in which a US team have trialled a potential new treatment for prostate cancer in patients for the first time.